News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
35,924 Results
Type
Article (1609)
Company Profile (6)
Press Release (34309)
Section
Business (15518)
Career Advice (125)
Deals (2305)
Drug Development (3719)
Employer Resources (1)
FDA (566)
Job Trends (784)
News (21209)
Policy (1140)
Tag
Academia (47)
Accelerated approval (1)
Allergies (5)
Alliances (1225)
ALS (1)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (7)
Approvals (583)
Artificial intelligence (4)
Autoimmune disease (3)
Automation (1)
Bankruptcy (6)
Best Places to Work (740)
Biosimilars (3)
Biotechnology (6)
Bladder cancer (2)
Breast cancer (21)
Cancer (121)
Cardiovascular disease (12)
Career advice (123)
Career pathing (1)
CAR-T (4)
Cell therapy (13)
Cervical cancer (2)
Clinical research (3243)
Collaboration (24)
Compensation (8)
COVID-19 (66)
CRISPR (2)
C-suite (5)
Cystic fibrosis (12)
Data (153)
Depression (1)
Diabetes (15)
Diagnostics (282)
Digital health (1)
Drug discovery (6)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (2)
Earnings (13715)
Employer resources (1)
Events (3623)
Executive appointments (6)
FDA (674)
Frontotemporal dementia (1)
Funding (23)
Gene editing (4)
Gene therapy (10)
GLP-1 (24)
Government (90)
Guidances (60)
Healthcare (902)
IgA nephropathy (8)
Immunology and inflammation (4)
Indications (4)
Infectious disease (73)
Inflammatory bowel disease (4)
Influenza (1)
Intellectual property (4)
Interviews (12)
IPO (1666)
Job creations (91)
Job search strategy (113)
Labor market (3)
Layoffs (11)
Legal (195)
Liver cancer (6)
Lung cancer (18)
Lymphoma (15)
Management (1)
Manufacturing (2)
MASH (1)
Medical device (794)
Medtech (794)
Mergers & acquisitions (666)
Metabolic disorders (24)
Multiple sclerosis (5)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (62)
NextGen: Class of 2025 (190)
Non-profit (83)
Now hiring (1)
Obesity (9)
Opinion (3)
Ovarian cancer (2)
Pain (2)
Pancreatic cancer (1)
Parkinson's disease (2)
Patents (6)
Patient recruitment (5)
Peanut (4)
People (1037)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (789)
Phase II (1260)
Phase III (1377)
Pipeline (276)
Policy (1)
Postmarket research (180)
Preclinical (259)
Press Release (1)
Prostate cancer (7)
Radiopharmaceuticals (10)
Rare diseases (25)
Real estate (154)
Regulatory (943)
Reports (2)
Research institute (48)
Resumes & cover letters (10)
RSV (5)
Schizophrenia (2)
Series A (7)
Series B (5)
Sickle cell disease (7)
Spinal muscular atrophy (11)
Startups (92)
Tariffs (1)
The Weekly (1)
Vaccines (14)
Venture capitalists (3)
Weight loss (3)
Date
Last 7 days (105)
Last 30 days (200)
Last 365 days (2019)
2025 (697)
2024 (2235)
2023 (2389)
2022 (3550)
2021 (4092)
2020 (3474)
2019 (1831)
2018 (1318)
2017 (1139)
2016 (718)
2015 (1180)
2014 (784)
2013 (418)
2012 (514)
2011 (683)
2010 (642)
Location
Africa (65)
Alabama (5)
Arizona (8)
Asia (2076)
Australia (310)
California (430)
Canada (102)
China (20)
Colorado (20)
Connecticut (8)
Delaware (14)
Europe (4042)
Florida (58)
Georgia (14)
Idaho (3)
Illinois (30)
India (1)
Indiana (26)
Japan (17)
Kansas (3)
Kentucky (2)
Louisiana (3)
Maine (8)
Maryland (57)
Massachusetts (277)
Michigan (14)
Minnesota (29)
Missouri (2)
Montana (2)
Nevada (2)
New Hampshire (5)
New Jersey (147)
New Mexico (1)
New York (116)
North Carolina (42)
Northern California (206)
Ohio (10)
Pennsylvania (105)
South America (73)
Southern California (182)
Tennessee (2)
Texas (44)
United States (1492)
Utah (14)
Virginia (3)
Washington D.C. (4)
Washington State (31)
Wisconsin (3)
35,924 Results for "105".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
March 26, 2025
·
4 min read
Press Releases
Aligos Therapeutics Announces $105 Million Private Placement Financing
February 12, 2025
·
5 min read
Press Releases
Upstream Bioprocessing Market Size to Reach $105.46 Bn by 2034
February 17, 2025
·
1 min read
Press Releases
Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung Cancer
April 17, 2025
·
4 min read
Press Releases
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
April 23, 2025
·
4 min read
Press Releases
Kairos Pharma Adds Huntsman Cancer Institute for Phase 2 ENV105 Clinical Trial
February 12, 2025
·
3 min read
Press Releases
Kairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate Cancer
April 1, 2025
·
4 min read
Press Releases
Cidara Therapeutics Announces $105 Million Private Placement
November 21, 2024
·
5 min read
Press Releases
LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 11, 2025
·
5 min read
Press Releases
LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 14, 2025
·
5 min read
1 of 3,593
Next
